Medikit announces share buyback, dividend hike, and strong first-half results

Medikit announced a resolution to acquire up to 150,000 shares of its common stock, representing 1.03% of outstanding shares, for a maximum of JPY 409,800,000. The acquisition will occur on November 13, 2025, via ToSTNeT-3 at JPY 2,732 per share, matching the November 12, 2025 closing price. This move aims to enhance capital efficiency and shareholder returns.

Concurrently, Medikit approved an interim dividend of JPY 50.00 per share for the period ended September 30, 2025, an increase from JPY 45.00 in the previous year. The total dividend payout will be JPY 731m, with an effective date of December 17, 2025. This aligns with the company's commitment to stable and continuous returns to shareholders.

Medikit also reported strong financial results for the first half of fiscal year 2026 (April 1 to September 30, 2025), with net sales increasing by 5.6% to JPY 11,921m, operating income up 1.0% to JPY 2,242m, and net income attributable to owners of the parent rising 5.6% to JPY 1,350m. Full-year forecasts remain unchanged, projecting JPY 24,000m in net sales and a total annual dividend of JPY 100.00 per share.